ImageneBio, Inc. Basic Shares Outstanding (Weighted Average)
ImageneBio, Inc. (IMA) reported Basic Shares Outstanding (Weighted Average) of 11.21 million shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-05-07
- ImageneBio, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 11.21M shares, a 695.15% increase year-over-year.
- ImageneBio, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 8.06M shares, a 470.83% increase year-over-year.
- ImageneBio, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 8.53M shares, a 508.81% increase year-over-year.
- ImageneBio, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-06-30 was 48.26M shares, a 0.00% change year-over-year.
- ImageneBio, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 4.87M shares, a 307.89% increase from fiscal 2024.
- ImageneBio, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 1.19M shares, a 97.14% decline from fiscal 2023.
- ImageneBio, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 41.74M shares, a 15.33% increase from fiscal 2022.
- ImageneBio, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 36.19M shares, a 29.32% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | 11.21M shares 10-Q · filed 2026-05-07 | 9.63M shares derived: average of 2 quarters · filed 2026-05-07 | 9.27M shares derived: average of 3 quarters · filed 2026-05-07 | 19.01M shares derived: average of 4 quarters · filed 2026-05-07 | |||
| 2025-12-31 | 8.06M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | 8.29M shares derived: average of 2 quarters · filed 2026-03-10 | 21.61M shares derived: average of 3 quarters · filed 2026-03-10 | 4.87M shares 10-K · filed 2026-03-10 | |||
| 2025-09-30 | 8.53M shares 10-Q · filed 2025-11-12 | 28.39M shares derived: average of 2 quarters · filed 2025-11-12 | 3.81M shares 10-Q · filed 2025-11-12 | 14.90M shares derived: average of 4 quarters · filed 2026-05-07 | |||
| 2025-06-30 | 48.26M shares 10-Q · filed 2025-07-24 | 48.26M shares 10-Q · filed 2025-07-24 | 17.03M shares derived: average of 3 quarters · filed 2026-05-07 | 13.12M shares derived: average of 4 quarters · filed 2026-05-07 | |||
| 2025-03-31 | 1.41M shares 10-Q · filed 2026-05-07 | 48.26M shares 10-Q · filed 2025-05-08 | 1.41M shares derived: average of 2 quarters · filed 2026-05-07 | 1.41M shares derived: average of 3 quarters · filed 2026-05-07 | 13.12M shares derived: average of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | 1.41M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | 1.41M shares derived: average of 2 quarters · filed 2026-03-10 | 17.02M shares derived: average of 3 quarters · filed 2026-03-10 | 1.19M shares 10-K · filed 2026-03-10 | 48.26M shares 10-K · filed 2025-03-06 | ||
| 2024-09-30 | 1.40M shares 10-Q · filed 2025-11-12 | 48.26M shares 10-Q · filed 2024-11-07 | 24.83M shares derived: average of 2 quarters · filed 2025-11-12 | 1.12M shares 10-Q · filed 2025-11-12 | 48.26M shares 10-Q · filed 2024-11-07 | 36.45M shares derived: average of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | 48.26M shares 10-Q · filed 2025-07-24 | 48.26M shares 10-Q · filed 2025-07-24 | 48.13M shares derived: average of 3 quarters · filed 2025-07-24 | 46.96M shares derived: average of 4 quarters · filed 2025-07-24 | |||
| 2024-03-31 | 48.26M shares 10-Q · filed 2025-05-08 | 48.07M shares derived: average of 2 quarters · filed 2025-05-08 | 46.52M shares derived: average of 3 quarters · filed 2025-05-08 | 44.72M shares derived: average of 4 quarters · filed 2025-05-08 | |||
| 2023-12-31 | 47.87M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | 45.66M shares derived: average of 2 quarters · filed 2025-03-06 | 43.53M shares derived: average of 3 quarters · filed 2025-03-06 | 41.74M shares 10-K · filed 2025-03-06 | |||
| 2023-09-30 | 43.44M shares 10-Q · filed 2024-11-07 | 41.37M shares derived: average of 2 quarters · filed 2024-11-07 | 39.69M shares 10-Q · filed 2024-11-07 | 38.81M shares derived: average of 4 quarters · filed 2024-11-07 | |||
| 2023-06-30 | 39.29M shares 10-Q · filed 2024-08-08 | 37.78M shares 10-Q · filed 2024-08-08 | 37.27M shares derived: average of 3 quarters · filed 2024-08-08 | 37.02M shares derived: average of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | 36.26M shares 10-Q · filed 2024-05-13 | 36.26M shares derived: average of 2 quarters · filed 2024-05-13 | 36.26M shares derived: average of 3 quarters · filed 2024-05-13 | 36.23M shares derived: average of 4 quarters · filed 2024-05-13 | |||
| 2022-12-31 | 36.26M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | 36.26M shares derived: average of 2 quarters · filed 2024-03-12 | 36.23M shares derived: average of 3 quarters · filed 2024-03-12 | 36.19M shares 10-K · filed 2024-03-12 | |||
| 2022-09-30 | 36.26M shares 10-Q · filed 2023-11-09 | 36.21M shares derived: average of 2 quarters · filed 2023-11-09 | 36.17M shares 10-Q · filed 2023-11-09 | 36.13M shares derived: average of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | 36.16M shares 10-Q · filed 2023-08-10 | 36.12M shares 10-Q · filed 2023-08-10 | 36.08M shares derived: average of 3 quarters · filed 2023-08-10 | 36.03M shares derived: average of 4 quarters · filed 2023-08-10 | |||
| 2022-03-31 | 36.08M shares 10-Q · filed 2023-05-15 | 36.05M shares derived: average of 2 quarters · filed 2023-05-15 | 35.98M shares derived: average of 3 quarters · filed 2023-05-15 | 35.95M shares derived: average of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | 36.02M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | 35.94M shares derived: average of 2 quarters · filed 2023-03-14 | 35.91M shares derived: average of 3 quarters · filed 2023-03-14 | 27.98M shares 10-K · filed 2023-03-14 | |||
| 2021-09-30 | 35.86M shares 10-Q · filed 2022-11-07 | 35.86M shares derived: average of 2 quarters · filed 2022-11-07 | 25.31M shares 10-Q · filed 2022-11-07 | ||||
| 2021-06-30 | 35.85M shares 10-Q · filed 2022-08-11 | 19.94M shares 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |